22 Nov 2022 Hong Kong unemployment rate dropped slightly from 3.9% (May to Jul) to 3.8% (Aug to Oct), while the underemployment rate also fell by 0.1ppt QoQ to 1.7%. During the same period, the number of unemployed citizens decreased
16 Nov 2022 Man Wah reported its Sept ended 1HFY23 results with top line decreased by 8.0% YoY to HK$9.5bn and NP increased by 10.5% YoY to HK$1.1bn. Gross profit dropped by 2.5% YoY to HK$3.6bn with overall GPM increased
15 Nov 2022 Newly debuted on HKEX in July this year, MicroPort NeuroTech (MNT) is a medical device company for treating neurovascular disease. Since its first product approval in 2004, the company has built up a diversified products portfolio for
09 Nov 2022 Channel Micron is a leading cleanroom system provider based in China and Malaysia. The company was founded in 1989 in Malaysia and listed in HKEX in 2020. The company’s “Channel Systems” brand was established for cleanroom wall
09 Nov 2022 Following a spectacular FY22, Precision Tsugami (China) (PTC) encountered headwinds in 1H23 (FY ended Mar) due to the resurgence of COVID-19 pandemic in Eastern China, especially Shanghai. Under the strict prevention and control measures, this had greatly
07 Nov 2022 Increasing investment in China semiconductor industry drives demand for cleanroom facilities. Cleanroom environment is very important in semiconductor industry.
07 Nov 2022 China government strongly supports the development of its semiconductor industry. In the 14th Five Year Plan, the development of semiconductor industry has been made a national priority and targets 70% chips self-sufficiency ratio by 2025. According to
07 Nov 2022 Suntien reported its 3Q22 P/L and operating data, with 3Q22 revenue up by 22.8% YoY to Rmb2.82bn and adjusted NP (after deducting non-recurring items) was at Rmb43.4m, compared to adj. net loss of Rmb56.2m in 3Q21. 9M22
07 Nov 2022 Listed in 2021, MicroPort CardioFlow (MCF) is a medical device company focusing on the R&D, commercialization of innovative transcatheter and surgical solutions for valvular heart diseases. The company’s products help to improve the lives of valvular heart
01 Nov 2022 Xtep reported its 3Q22 operational data with retail sales grew by 20-25% YoY. July/August saw robust growth of ~25%/~30% YoY, but Sept growth slowed down to low-teens YoY due to the negative impact from the pandemic situation
